Prenatal and Newborn Genetic Testing Market

Global Prenatal and Newborn Genetic Testing Market Size, Trends & Analysis - Forecasts to 2027 By Diagnostic (Chorionic Villus Sampling, Amniocentesis, Maternal Serum Screening, Non-invasive Prenatal Testing, PCR, Spectrophotometer, FISH, Array-Comparative Genomic Hybridization), By Disease Type (Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle cell Anaemia), By End-Use (Hospitals, Maternity and Specialty Clinics, Diagnostic Centres), By Region (North America, Asia Pacific, Central, and South America, Europe, and the Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on November 16 2024 with the latest and most recent market numbers

Global Prenatal and Newborn Genetic Testing Market Size

The Global Prenatal and Newborn Genetic Testing Market is projected to grow from USD 5.2 Billion in 2022 to USD 8.6 Billion in 2027 at a CAGR of 14.5% from 2022 to 2027.

The growth of the diagnostic industry is expected to be increasing rapidly owing to trends such as rising public and private investments, increasing number of diagnostic companies in developing and 3rd world nations, and rising awareness amongst end-users about screening and vital diagnostic procedures. The significant contenders who are dominating this industry such as Bio-Rad laboratories Inc, Agilent Technologies Inc, Illumina, and Quest Diagnostic Incorporated, among others are investing billions of dollars in the field of both human and neonatal diagnostic segment. The majority of expenditures in diagnostics are made by top healthcare and medical device players as their internal corporate spending in order to improve their diagnostics capabilities. These businesses are also stepping up their investments in Healthcare start-ups like HealX, and Embleema.

Technology advances and growing benefits in prenatal testing and newborn genetic screening, the prevalence of genetic disorders and chromosomal abnormalities, rising consanguineous relationships, government initiatives and support for prenatal testing and newborn genetic screening, and an increase in the use of non-invasive prenatal testing are some of the factors driving the growth of the prenatal and newborn genetic testing market.

Due to the rising occurrence of genetic abnormalities in infants such as Down syndrome, Patau syndrome, and Edwards syndrome, the market for prenatal and newborn genetic testing is growing. Finding genetic abnormalities in babies and during pregnancy is becoming more and more popular. Additionally, the market is expanding steadily due to investments made in genetic disorder testing research and development as well as the adoption of new technology.

global prenatal and newborn genetic testing market

COVID-19 Impact on Global Prenatal and Newborn Genetic Testing Market

The COVID-19 pandemic has heightened global demand for diagnostics, medical devices and pharmaceuticals industry. The prenatal and newborn genetic testing market was slightly hampered owing to the restrictions imposed by the government on the movement of patients to hospitals for any other purposes other than COVID-19 related tests, treatment and diagnosis.

Additionally, this market experienced a significant decline as a result of the closure of laboratories for the similar reason. In order to stay informed of any supply chain problems, many manufacturers kept in regular contact with the U.S. FDA. A number of research studies were also carried out to calculate COVID-19's impact on the economy. In order to identify the impact of COVID-19 infection on gestation and congenital defects in infants as well as the need for NIPT during the COVID-19 pandemic, IVD manufacturers and clinical testing facilities worked with research groups. However, the market is anticipated to rebound and grow exponentially as a result of rising pregnancy rates and loosening regulations.

Global Prenatal and Newborn Genetic Testing Market: By Diagnostic

The maternal serum screening segment is expected to be the fastest-growing segment in the market from 2022 to 2027. Carrier screening, sequential screening, and maternal serum quad screening are three examples of screenings.

Global Prenatal and Newborn Genetic Testing Market: By Disease Type

As of 2022, the Down Syndrome sector holds the largest share of prenatal and infant genetic testing market. The increase in incidences of Down syndrome and government efforts to combat it, are responsible for the segment's growth.

The second-largest market share for prenatal and infant genetic testing belongs to cystic fibrosis. A significant growth element is the increase in new instances of cystic fibrosis. 70,000 to 100,000 persons globally suffer from cystic fibrosis. The Cystic Fibrosis Foundation estimates that 40,000 children and adults in the United States have the disease. Each year, roughly 1,000 new cases are diagnosed in the United States.

Global Prenatal and Newborn Genetic Testing Market: By End-User

As of 2022, the hospitals segment holds the largest market share for prenatal and infant genetic testing. The rising number of new hospitals, and increasing government spending on procuring neonatal medical devices and diagnostic services are some of the factors contributing to the growth of the segment in the market.

asia pacific prenatal and newborn genetic testing market

Global Prenatal and Newborn Genetic Testing Market: By Region

North America will have a dominant share in the market from 2022 to 2027. This is due to the large number of hospital and clinics who use prenatal and newborn genetic testing devices, which has resulted in a higher demand for diagnostics enabled solutions. Moreover, rising prevalance of neonatal disorders, and increasing awareness regarding newborn screening devices are expected to help grow the market.

Asia Pacific is expected to grow rapidly in the market. This is mainly attributed to increased investments in diagnostics technology and increased demand for newborn screening and diagnostic services. Additionally, the market is anticipated to be significantly impacted by the region's supportive government initiatives and expanding evolution.

Europe held a significant market share in 2021. High R&D investments, high preterm birth rate, a well-established research framework, and the development of whole-genome sequencing in the region are among the factors anticipated to boost the growth of the market

Global Prenatal and Newborn Genetic Testing Market Share and Competitor Analysis

Bio-Rad Laboratories Inc, Agilent Technologies Inc, Illumina, Qiagen NV, Sequenom, BGI group, and Quest Diagnostic Incorporated, among others, are some of the key players in the prenatal and newborn genetic testing market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Research Methodology

1.1 Research Assumptions

1.2 Research Methodology

1.2.1 Estimates and Forecast Timeline

1.3 Information Procurement

1.3.1 Purchased Database

1.3.2 GME’s Internal Database

1.3.3 Primary Research

1.3.4 Secondary Sources & Third-Party Perspectives

1.3.4.1 Company Information Sources: Annual Reports, Investor Presentation, Press Release, SEC Filing, Company Blogs & Website

1.3.4.2 Secondary Data Sources

1.4 Information or Data Analysis

1.4.1 Data Analysis Models

1.5 Market Application & Data Visualization

1.6 Data Validation & Publishing

1.7 Market Model

1.7.1 Model Details

1.7.1.1 Top-Down Approach

1.7.1.2 Bottom-Up Approach

1.8 Market Segmentation & Scope

1.9 Market Definition

Chapter 2 Executive Summary

2.1. Global Market Outlook

2.2 Diagnostic Outlook

2.3 Disease Type Outlook

2.4 End-User Outlook

2.5 Regional Outlook

Chapter 3 Global Prenatal and Newborn Genetic Testing Market Trend Analysis

3.1. Market Introduction

3.2 Penetration & Growth Prospect Mapping

3.3 Impact of COVID-19 on the Prenatal and Newborn Genetic Testing Market

3.4 Metric Data on Diagnostics Industry

3.5 Market Dynamic

3.5.1 Market Driver Analysis

3.5.2 Market Restraint Analysis

3.5.3 Industry Challenges

3.5.4 Industry Opportunities

3.6 Porter’s Five Analysis

3.7 Market Entry Strategies

Chapter 4 Global Prenatal Newborn Genetic Testing Market: Diagnostic Trend Analysis

4.1 Chorionic Villus Sampling

4.1.1 Market Estimates & Forecast Analysis of Chorionic Villus Sampling Segment, By Region, 2019-2027 (USD Billion)

4.2 Amniocentesis

4.2.1 Market Estimates & Forecast Analysis of Amniocentesis Segment, By Region, 2019-2027 (USD Billion)

4.3 Maternal Serum Screening

4.3.1 Market Estimates & Forecast Analysis of Maternal Serum Screening Segment, By Region, 2019-2027 (USD Billion)

4.4 Non-Invasive Prenatal Testing (NIPT)

4.4.1 Market Estimates & Forecast Analysis of Non-Invasive Prenatal Testing (NIPT)Segment, By Region, 2019-2027 (USD Billion)

4.5 PCR

4.5.1 Market Estimates & Forecast Analysis of PCR Segment, By Region, 2019-2027 (USD Billion)

4.6 Spectrophotometer

4.6.1 Market Estimates & Forecast Analysis of Spectrophotometer Segment, By Region, 2019-2027 (USD Billion)

4.7 FISH

4.7.1 Market Estimates & Forecast Analysis of FISH Segment, By Region, 2019-2027 (USD Billion)

4.8 Array-Comparative Genomic Hybridization

4.8.1 Market Estimates & Forecast Analysis of Array-Comparative Genomic Hybridization Segment, By Region, 2019-2027 (USD Billion)

Chapter 5 Global Prenatal Newborn Genetic testing Market: Disease Types Trend Analysis

5.1 Disease Types: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027

5.2 Down’s Syndrome

5.2.1 Market Estimates & Forecast Analysis of Down’s syndrome Segment, By Region, 2019-2027 (USD Billion)

5.3 Cystic Fibrosis

5.3.1 Market Estimates & Forecast Analysis of Cystic Fibrosis Segment, By Region, 2019-2027 (USD Billion)

5.4 Phenylketonuria

5.4.1 Market Estimates & Forecast Analysis of Phenylketonuria Segment, By Region, 2019-2027 (USD Billion)

5.5 Sickle cell Anaemia

5.5.1 Market Estimates & Forecast Analysis of Sickle cell Anaemia Segment, By Region, 2019-2027 (USD Billion)

Chapter 6 Global prenatal Newborn Genetic Testing market: End-User Trend Analysis

6.1 Hospitals

6.1.1 Market Estimates & Forecast Analysis of Hospitals Segment, By Region, 2019-2027 (USD Billion)

6.2 Maternity and Specialty Clinics

6.2.1 Market Estimates & Forecast Analysis of Maternity and Specialty Clinics Segment, By Region, 2019-2027 (USD Billion)

6.3 Diagnostic Centres

6.3.1 Market Estimates & Forecast Analysis of Diagnostic Centres Segment, By Region, 2019-2027 (USD Billion)

Chapter 7 Global Prenatal and Newborn Genetic Testing Market, By Region

7.1 Regional Outlook

7.2 North America

7.2.1 Market Estimates & Forecast Analysis, By Country 2019-2027(USD Billion)

7.2.2 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.2.3 Market Estimates & Forecast Analysis, By Disease Type, 2019-2027(USD Billion)

7.2.5 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.2.6 U.S.

7.2.6.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.2.6.2 Market Estimates & Forecast Analysis, By Disease Type, 2019-2027(USD Billion)

7.2.6.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.2.7 Canada

7.2.7.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.2.7.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.2.7.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.2.8 Mexico

7.2.7.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027 (USD Billion)

7.2.7.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027 (USD Billion)

7.2.7.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.3 Europe

7.3.1 Market Estimates & Forecast Analysis, By Country 2019-2027(USD Billion)

7.3.2 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.3.3 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.3.5 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.3.6 Germany

7.3.6.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.3.6.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.3.6.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.3.7 UK

7.3.7.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.3.7.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.3.7.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.3.8 France

7.3.7.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.3.7.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.3.7.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.3.9 Netherlands

7.3.9.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.3.9.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.3.9.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.3.10 Italy

7.3.10.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.3.10.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.3.10.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.3.11 Spain

7.3.11.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.3.11.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.3.11.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.3.12 Rest of Europe

7.3.12.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027 (USD Billion)

7.3.12.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027 (USD Billion)

7.3.12.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.4 Asia Pacific

7.4.1 Market Estimates & Forecast Analysis, By Country 2019-2027(USD Billion)

7.4.2 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.4.3 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.4.5 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.4.6 China

7.4.6.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.4.6.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.4.6.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.4.7 India

7.4.7.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.4.7.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.4.7.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.4.8 Japan

7.4.7.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.4.7.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.4.7.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.4.9 Thailand

7.4.9.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.4.9.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.4.9.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.4.10 South Korea

7.4.10.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.4.10.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.4.10.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.4.11 Indonesia

7.4.11.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.4.11.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.4.11.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.4.12 Malaysia

7.4.12.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.4.12.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.4.12.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.4.13 Singapore

7.4.13.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.4.13.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.4.13.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.4.14 Vietnam

7.4.14.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.4.14.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.4.14.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.4.15 Rest of Asia Pacific

7.4.15.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027 (USD Billion)

7.4.15.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027 (USD Billion)

7.4.15.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.5 Central & South America

7.5.1 Market Estimates & Forecast Analysis, By Country 2019-2027(USD Billion)

7.5.2 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.5.4 Market Estimates & Forecast Analysis, By Application, 2019-2027(USD Billion)

7.5.5 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.5.6 Brazil

7.5.6.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.5.6.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.5.6.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.5.7 Argentina

7.5.7.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.5.7.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.5.7.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.5.8 Chile

7.5.7.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.5.7.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.5.7.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.5.7 Rest of Central & South America

7.5.7.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.5.7.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.5.7.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.6 Middle East & Africa

7.6.1 Market Estimates & Forecast Analysis, By Country 2019-2027(USD Billion)

7.6.2 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.6.3 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.6.5 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.6.6 Saudi Arabia

7.6.6.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.6.6.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.6.6.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.6.7 United Arab Emirates

7.6.7.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.6.7.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.6.7.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.6.8 South Africa

7.6.7.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.6.7.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.6.7.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.6.8 Israel

7.6.9.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027(USD Billion)

7.6.9.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027(USD Billion)

7.6.9.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

7.6.10 Rest of Middle East & Africa

7.6.10.1 Market Estimates & Forecast Analysis, By Diagnostic, 2019-2027 (USD Billion)

7.6.10.2 Market Estimates & Forecast Analysis, By Disease Types, 2019-2027 (USD Billion)

7.6.10.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)

Chapter 9 Competitive Analysis

9.1 Key Global Players, Recent Developments & their Impact on the Industry

9.2 Four Quadrant Competitor Positioning Matrix

9.2.1 Key Innovators

9.2.2 Market Leaders

9.2.3 Emerging Players

9.2.4 Market Challengers

9.3 Vendor Landscape Analysis

9.4 End-User Landscape Analysis

9.5 Company Market Share Analysis, 2021

Chapter 10 Company Profile Analysis

10.1 Bio-Rad Laboratories Inc

10.1.1 Company Overview

10.1.2 Financial Analysis

10.1.3 Strategic Initiatives

10.1.4 Product Benchmarking

10.2 Agilent Technologies Inc

10.2.1 Company Overview

10.2.2 Financial Analysis

10.2.3 Strategic Initiatives

10.2.4 Product Benchmarking

10.3 Illumina Inc.

10.3.1 Company Overview

10.3.2 Financial Analysis

10.3.3 Strategic Initiatives

10.3.4 Product Benchmarking

10.4 Qiagen NV

10.4.1 Company Overview

10.4.2 Financial Analysis

10.4.3 Strategic Initiatives

10.4.4 Product Benchmarking

10.5 Sequenom

10.5.1 Company Overview

10.5.2 Financial Analysis

10.5.3 Strategic Initiatives

10.5.4 Product Benchmarking

10.6 Quest Diagnostic

10.6.1 Company Overview

10.6.2 Financial Analysis

10.6.3 Strategic Initiatives

10.6.4 Product Benchmarking

10.7 BGI Group

10.7.1 Company Overview

10.7.2 Financial Analysis

10.7.3 Strategic Initiatives

10.7.4 Product Benchmarking

10.10 Other Companies

10.11.1 Company Overview

10.11.2 Financial Analysis

10.11.3 Strategic Initiatives

10.11.4 Product Benchmarking

List of Tables

1 North America: Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

2 North America: Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

3 North America: Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

4 North America: Global Prenatal and Newborn Genetic Testing Market, By Country, 2019-2027 (USD Billion)

5 U.S :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

6 U.S :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

7 U.S :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

8 Canada :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

9 Canada :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

10 Canada :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

11 Mexico :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

12 Mexico :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

13 Mexico :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

14 Europe :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

15 Europe :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

16 Europe :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

17 Germany :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

18 Germany :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

19 Germany :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

20 UK :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

21 UK :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

22 UK :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

23 France :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

24 France :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

25 France :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

26 Italy :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

27 Italy :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

28 ltaly :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

29 Spain :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

30 Spain :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

31 Spain :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

32 Netherlands :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

33 Netherlands :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

34 Netherlands :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

35 Rest Of Europe :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

36 Rest Of Europe :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

37 Rest of Europe :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

38 Asia Pacific :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

39 Asia Pacific :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

40 Asia Pacific :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

41 Asia Pacific :Global Prenatal and Newborn Genetic Testing Market, By Country, 2019-2027 (USD Billion)

42 China :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

43 China :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

44 China :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

45 India :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

46 India :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

47 India :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

48 Japan :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

49 Japan :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

50 Japan :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

51 South Korea :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

52 South Korea :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

53 South Korea :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

54 Thailand :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

55 Thailand :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

56 Thailand :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

57 Indonesia :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

58 Indonesia :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

59 Indonesia :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

60 Malaysia :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

61 Malaysia :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

62 Malaysia :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

63 Singapore :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

64 Singapore :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

65 Singapore :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

66 Vietnam :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

67 Vietnam :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

68 Vietnam :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

69 Rest of Asia Pacific :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

70 Rest of Asia Pacific :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

71 Rest of Asia Pacific :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

72 Middle East & Africa :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

73 Middle East & Africa :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

74 Middle East & Africa :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

75 Middle East & Africa :Global Prenatal and Newborn Genetic Testing Market, By Country, 2019-2027 (USD Billion)

76 Saudi Arabia :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

77 Saudi Arabia :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

78 Saudi Arabia :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

79 UAE :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

80 UAE :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

81 UAE :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

82 South Africa :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

83 South Africa :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

84 South Africa :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

85 Israel :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

86 Israel :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

87 Israel :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

88 Rest of Middle East & Africa :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

89 Rest of Middle East & Africa :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

90 Rest of Middle East & Africa :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

91 Central & South America: Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

92 Central & South America: Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

93 Central & South America: Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

94 Central & South America: Global Prenatal and Newborn Genetic Testing Market, By Country, 2019-2027 (USD Billion)

95 Brazil :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

96 Brazil :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

97 Brazil :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

98 Argentina :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

99 Argentina :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

100 Argentina :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

101 Chile :Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

102 Chile :Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

103 Chile :Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

104 Rest of Central & South America: Global Prenatal and Newborn Genetic Testing Market, By Diagnostic, 2019-2027 (USD Billion)

105 Rest of Central & South America: Global Prenatal and Newborn Genetic Testing Market, By Disease Types, 2019-2027 (USD Billion)

106 Rest of Central & South America: Global Prenatal and Newborn Genetic Testing Market, By End-User, 2019-2027 (USD Billion)

107 Bio-Rad Laboratories Inc: Products Offered

108 Agilent Technologies Inc: Products Offered

109 Illumina: Products Offered

110 Qiagen NV: Products Offered

111 Sequenom: Products Offered

112 BGI Group: Products Offered

113 Quest Diagnostic Incorporated: Products Offered

114 Other Companies: Products Offered

List of Figures

1. Global Prenatal and Newborn Genetic Testing Market Segmentation & Research Scope

2. Primary Research Partners and Local Informers

3. Primary Research Process

4. Primary Research Approaches

5. Primary Research Responses

6. Global Prenatal and Newborn Genetic Testing Market: Penetration & Growth Prospect Mapping

7. Global Prenatal and Newborn Genetic Testing Market: Value Chain Analysis

8. Global Prenatal and Newborn Genetic Testing Market Drivers

9. Global Prenatal and Newborn Genetic Testing Market Restraints

10. Global Prenatal and Newborn Genetic Testing Market Opportunities

11. Global Prenatal and Newborn Genetic Testing Market Challenges

12. Key Global Prenatal and Newborn Genetic Testing Market Manufacturer Analysis

13. Global Prenatal and Newborn Genetic Testing Market: Porter’s Five Forces Analysis

14. PESTLE Analysis & Impact Analysis

15. Bio-Rad Laboratories Inc: Company Snapshot

16. Bio-Rad Laboratories Inc: Swot Analysis

17. Agilent Technologies Inc: Company Snapshot

18. Agilent Technologies Inc: Swot Analysis

19. Illumina: Company Snapshot

20. Illumina: Swot Analysis

21. Qiagen NV: Company Snapshot

22. Qiagen NV: Swot Analysis

23. Sequenom: Company Snapshot

24. Sequenom: Swot Analysis

25. BGI Group: Company Snapshot

26. BGI Group: Swot Analysis

27. Quest Diagnostic Incorporated: Company Snapshot

28. Quest Diagnostic Incorporated: Swot Analysis

29. Other Companies: Company Snapshot

30. Other Companies: Swot Analysis

The Global Prenatal and Newborn Genetic Testing Market has been studied from the year 2019 till 2027. However, the CAGR provided in the report is from the year 2022 to 2027. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Prenatal and Newborn Genetic Testing Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.